In patients with obesity, we found an increased risk of a clinical event in CRP-Q4 (CRP-Q4, HRadj: 1.73 [95% CI = 0.78–3.83]), though the precision of the estimate was less precise. This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.